| Miss Supriti Paul, MD | |
|
6010 Hidden Valley Rd Ste 210, Carlsbad, CA 92011-4219 | |
| (858) 755-9343 | |
| (858) 792-1790 |
| Full Name | Miss Supriti Paul |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 20 Years |
| Location | 6010 Hidden Valley Rd Ste 210, Carlsbad, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316063936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD32356 (South Carolina) | Secondary |
| 207Y00000X | Otolaryngology | A120434 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Scripps Memorial Hospital - Encinitas | Encinitas, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacific Ent Medical Group, Inc. | 1759280274 | 4 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
Patients with epilepsy and, in particular, those with severe syndromic forms of the disorder, harbor a risk of sudden unexplained death in epilepsy, or SUDEP. Cardiac arrhythmias are a proposed cause. In a test of this theory, researchers have demonstrated that mice harboring a human SCN1A gene mutation that results in Dravet Syndrome, a severe and intractable genetic epilepsy, have electrical disturbances in the heart that culminate in ventricular fibrillation and sudden cardiac death.
As part of the celebration for Cinco de Mayo 2004, the U.S. Food and Drug Administration (FDA) and the National Alliance for Hispanic Health (NAHH) today strengthened their commitment to work together to improve access to health information, especially to Hispanic communities in the United States.
As hospitals look for ways to stem the opioid crisis, a survey of health-system pharmacy directors released today found that most large health systems have active stewardship programs to prevent the misuse of opioids - with pharmacists playing a key role in detecting drug diversion and identifying strategies to encourage appropriate opioid prescribing.
Giving children with Down's syndrome antioxidants and nutrients does not help their condition improve at all, according to a study published today on bmj.com.
› Verified 7 days ago
| Entity Name | Pacific Ent Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336249135 PECOS PAC ID: 1759280274 Enrollment ID: O20040105000271 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
Patients with epilepsy and, in particular, those with severe syndromic forms of the disorder, harbor a risk of sudden unexplained death in epilepsy, or SUDEP. Cardiac arrhythmias are a proposed cause. In a test of this theory, researchers have demonstrated that mice harboring a human SCN1A gene mutation that results in Dravet Syndrome, a severe and intractable genetic epilepsy, have electrical disturbances in the heart that culminate in ventricular fibrillation and sudden cardiac death.
As part of the celebration for Cinco de Mayo 2004, the U.S. Food and Drug Administration (FDA) and the National Alliance for Hispanic Health (NAHH) today strengthened their commitment to work together to improve access to health information, especially to Hispanic communities in the United States.
As hospitals look for ways to stem the opioid crisis, a survey of health-system pharmacy directors released today found that most large health systems have active stewardship programs to prevent the misuse of opioids - with pharmacists playing a key role in detecting drug diversion and identifying strategies to encourage appropriate opioid prescribing.
Giving children with Down's syndrome antioxidants and nutrients does not help their condition improve at all, according to a study published today on bmj.com.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Supriti Paul, MD 6010 Hidden Valley Rd Ste 210, Carlsbad, CA 92011-4219 Ph: (858) 755-9343 | Miss Supriti Paul, MD 6010 Hidden Valley Rd Ste 210, Carlsbad, CA 92011-4219 Ph: (858) 755-9343 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
Patients with epilepsy and, in particular, those with severe syndromic forms of the disorder, harbor a risk of sudden unexplained death in epilepsy, or SUDEP. Cardiac arrhythmias are a proposed cause. In a test of this theory, researchers have demonstrated that mice harboring a human SCN1A gene mutation that results in Dravet Syndrome, a severe and intractable genetic epilepsy, have electrical disturbances in the heart that culminate in ventricular fibrillation and sudden cardiac death.
As part of the celebration for Cinco de Mayo 2004, the U.S. Food and Drug Administration (FDA) and the National Alliance for Hispanic Health (NAHH) today strengthened their commitment to work together to improve access to health information, especially to Hispanic communities in the United States.
As hospitals look for ways to stem the opioid crisis, a survey of health-system pharmacy directors released today found that most large health systems have active stewardship programs to prevent the misuse of opioids - with pharmacists playing a key role in detecting drug diversion and identifying strategies to encourage appropriate opioid prescribing.
Giving children with Down's syndrome antioxidants and nutrients does not help their condition improve at all, according to a study published today on bmj.com.
› Verified 7 days ago
Vishal Banthia, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2390 Faraday Ave, Carlsbad, CA 92008 Phone: 858-909-0770 Fax: 858-909-0880 | |
Moses David Salgado, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6010 Hidden Valley Rd Ste 210, Carlsbad, CA 92011 Phone: 858-755-9343 Fax: 858-792-1790 | |
Dr. Ritvik Prakash Mehta, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2390 Faraday Ave, Carlsbad, CA 92008 Phone: 858-909-0770 Fax: 858-909-0880 |